bexarotene has been researched along with transforming growth factor alpha in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Drenning, SD; Grandis, JR; Hwang, JD; Lamph, WW; Lango, MN; Song, JI; Zeng, Q | 1 |
1 other study(ies) available for bexarotene and transforming growth factor alpha
Article | Year |
---|---|
Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
Topics: Animals; Anticarcinogenic Agents; Bexarotene; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Division; DNA-Binding Proteins; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Receptors, Retinoic Acid; Retinoid X Receptors; Signal Transduction; STAT3 Transcription Factor; Tetrahydronaphthalenes; Trans-Activators; Transcription Factors; Transforming Growth Factor alpha; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |